Calidad de vida en pacientes con cáncer de pulmón
Guardado en:
2256-2877
2256-2915
8
2021-10-01
7
9
http://purl.org/coar/access_right/c_abf2
info:eu-repo/semantics/openAccess
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Revista Colombiana de Hematología y Oncología - 2021
id |
a68bec2641d19bfb598eef5798509e7d |
---|---|
record_format |
ojs |
institution |
ASOCIACION COLOMBIANA DE HEMATOLOGIA Y ONCOLOGIA |
thumbnail |
https://nuevo.metarevistas.org/ASOCIACIONCOLOMBIANADEHEMATOLOGIAYONCOLOGIA/logo.png |
country_str |
Colombia |
collection |
Revista Colombiana de Hematología y Oncología |
title |
Calidad de vida en pacientes con cáncer de pulmón |
spellingShingle |
Calidad de vida en pacientes con cáncer de pulmón Yepes Pérez , Andrés Calidad de vida cáncer de pulmón |
title_short |
Calidad de vida en pacientes con cáncer de pulmón |
title_full |
Calidad de vida en pacientes con cáncer de pulmón |
title_fullStr |
Calidad de vida en pacientes con cáncer de pulmón |
title_full_unstemmed |
Calidad de vida en pacientes con cáncer de pulmón |
title_sort |
calidad de vida en pacientes con cáncer de pulmón |
title_eng |
Quality of life in patients with lung cancer |
author |
Yepes Pérez , Andrés |
author_facet |
Yepes Pérez , Andrés |
topicspa_str_mv |
Calidad de vida cáncer de pulmón |
topic |
Calidad de vida cáncer de pulmón |
topic_facet |
Calidad de vida cáncer de pulmón |
citationvolume |
8 |
citationissue |
1 |
citationedition |
Núm. 1 , Año 2021 : Enero-Junio |
publisher |
Asociación Colombiana de Hematología y Oncología (ACHO) |
ispartofjournal |
Revista Colombiana de Hematología y Oncología |
source |
https://revista.acho.info/index.php/acho/article/view/377 |
language |
Español |
format |
Article |
rights |
http://purl.org/coar/access_right/c_abf2 info:eu-repo/semantics/openAccess Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0. Revista Colombiana de Hematología y Oncología - 2021 https://creativecommons.org/licenses/by-nc-nd/4.0 |
references |
World Health Organization [Internet]. Lyon: International Agency for Research on Cancer. The Global Cancer Observatory. World fact sheet: Cancer; 2021 March [Consultado 9 agosto 2021]; Disponible en: http://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf. 2. Howlader N, Krapcho M, Miller D, et al. SEER cancer statistics review, 1975-2016 [November 2018 SEER data submission posted to the SEER web site, April 9, 2020]. Bethesda, MD: National Cancer Institute. Disponible en: https://seer.cancer.gov/csr/1975_2016/ 3. Koller M, Shamieh O, Hjermstad MJ, et al. European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group; EORTC Lung Cancer Group; European Society of Thoracic Surgeons. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study. Lancet Oncol. [Internet]. 2020;21(5):723-732. Disponible en: https://doi.org/10.1016/S1470-2045(20)30093-0 4. Ward EM, Sherman RL, Henley SJ, et al. Annual report to the nation on the status of cancer, featuring cancer in men and women age 20-49 years. J Natl Cancer Inst. [Internet]. 2019;111:1279-1297. Disponible en: https://doi.org/1093/jnci/djz106 5. Hardtstock, F., Myers, D., Li, T. et al. Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis. BMC Cancer. [Internet]. 2020;20:260-274. Disponible en: https://doi.org/10.1186/s12885-020-06738-z 6. Polanski J, Jankowska-Polanska B, Rosinczuk J, Chabowski M, Szymanska-Chabowska A. Quality of life of patients with lung cancer. Onco Targets Ther. [Internet]. 2016;9:1023-1028. Disponible en: https://doi.org/10.2147/OTT.S100685 7. Lemonnier I, Guillemin F, Arveux P, Clément-Duchêne C, Velten M, Woronoff-Lemsi MC, et al. Quality of life after the initial treatments of nonsmall cell lung cancer: a persistent predictor for patients’ survival. Health Qual Life Outcomes. [Internet]. 2014;12:73. Disponible en: https://doi.org/10.1186/1477-7525-12-73 8. Van Der Weijst L, Lievens Y, Schrauwen W and Surmont V. Health-Related Quality of Life in Advanced Non-small Cell Lung Cancer: A Methodological Appraisal Based on a Systematic Literature Review. Front. Oncol. [Internet]. 2019;9:715. Disponible en: https://doi.org/10.3389/fonc.2019.00715 9. Reale ML, Di Maio M. Quality of life in patients with lung cancer: the way forward. Lancet Oncol. [Internet]. 2020;21:617-619. Disponible en: https://doi.org/10.1016/S1470-2045(20)30151-0 10. Iyer S, Taylor-Stokes G, Roughley A. Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany. Lung Cancer. [Internet]. 2013;81(2):288–293. Disponible en: https://doi.org/10.1016/j.lungcan.2013.03.008 11. Bdira B, Aissa S, Houda R, Benzarti W, Knaz A, Hayouni A, Abdelghani A, Garrouch A, Benzarti M, Gargouri I. Factors associated with altered quality of life among lung cancer patients. Eur Respir J. [Internet]. 2019;54 (suppl 63) PA4655. Disponible en: https://doi.org/10.1183/13993003.congress-2019.PA4655 12. Bezjak A, Tu D, Seymour L, et al. Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR. 21. J Clin Oncol. [Internet]. 2006;24:3831–3837. Disponible en: https://doi.org/10.1200/JCO.2006.05.8073 13. Reck M, Wehler T, Orlandi F, et al. Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non-Small-Cell Lung Cancer. J Clin Oncol. [Internet]. 2020;38:2530-2542. Disponible en: https://doi.org/10.1200/JCO.19.03158 14. Hazell SZ, Fu W, Hu C, Voong KR, Lee B, Peterson V, Feliciano JL, Nicholas LH, McNutt TR, Han P, Hales RK. Financial toxicity in lung cancer: an assessment of magnitude, perception, and impact on quality of life. Ann Oncol. [Internet]. 2020;31(1):96-102. Disponible en: https://doi.org/10.1016/j.annonc.2019.10.006 15. Ramsey S, Bansal A, Fedorenko C, et al. Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol. 2016;34(9):980e986. Disponible en: https://doi.org/10.1200/JCO.2015.64.6620 |
type_driver |
info:eu-repo/semantics/article |
type_coar |
http://purl.org/coar/resource_type/c_b239 |
type_version |
info:eu-repo/semantics/publishedVersion |
type_coarversion |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
type_content |
Text |
publishDate |
2021-10-01 |
date_accessioned |
2021-10-01T19:10:11Z |
date_available |
2021-10-01T19:10:11Z |
url |
https://revista.acho.info/index.php/acho/article/view/377 |
url_doi |
https://doi.org/10.51643/22562915.377 |
issn |
2256-2877 |
eissn |
2256-2915 |
doi |
10.51643/22562915.377 |
citationstartpage |
7 |
citationendpage |
9 |
url2_str_mv |
https://revista.acho.info/index.php/acho/article/download/377/359 |
_version_ |
1797159783298498560 |
spelling |
Calidad de vida en pacientes con cáncer de pulmón https://revista.acho.info/index.php/acho/article/view/377 Text http://purl.org/coar/access_right/c_abf2 info:eu-repo/semantics/openAccess http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/publishedVersion http://purl.org/redcol/resource_type/ARTEDIT http://purl.org/coar/resource_type/c_b239 http://purl.org/coar/resource_type/c_6501 info:eu-repo/semantics/article World Health Organization [Internet]. Lyon: International Agency for Research on Cancer. The Global Cancer Observatory. World fact sheet: Cancer; 2021 March [Consultado 9 agosto 2021]; Disponible en: http://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf. 2. Howlader N, Krapcho M, Miller D, et al. SEER cancer statistics review, 1975-2016 [November 2018 SEER data submission posted to the SEER web site, April 9, 2020]. Bethesda, MD: National Cancer Institute. Disponible en: https://seer.cancer.gov/csr/1975_2016/ 3. Koller M, Shamieh O, Hjermstad MJ, et al. European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group; EORTC Lung Cancer Group; European Society of Thoracic Surgeons. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study. Lancet Oncol. [Internet]. 2020;21(5):723-732. Disponible en: https://doi.org/10.1016/S1470-2045(20)30093-0 4. Ward EM, Sherman RL, Henley SJ, et al. Annual report to the nation on the status of cancer, featuring cancer in men and women age 20-49 years. J Natl Cancer Inst. [Internet]. 2019;111:1279-1297. Disponible en: https://doi.org/1093/jnci/djz106 5. Hardtstock, F., Myers, D., Li, T. et al. Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis. BMC Cancer. [Internet]. 2020;20:260-274. Disponible en: https://doi.org/10.1186/s12885-020-06738-z 6. Polanski J, Jankowska-Polanska B, Rosinczuk J, Chabowski M, Szymanska-Chabowska A. Quality of life of patients with lung cancer. Onco Targets Ther. [Internet]. 2016;9:1023-1028. Disponible en: https://doi.org/10.2147/OTT.S100685 7. Lemonnier I, Guillemin F, Arveux P, Clément-Duchêne C, Velten M, Woronoff-Lemsi MC, et al. Quality of life after the initial treatments of nonsmall cell lung cancer: a persistent predictor for patients’ survival. Health Qual Life Outcomes. [Internet]. 2014;12:73. Disponible en: https://doi.org/10.1186/1477-7525-12-73 8. Van Der Weijst L, Lievens Y, Schrauwen W and Surmont V. Health-Related Quality of Life in Advanced Non-small Cell Lung Cancer: A Methodological Appraisal Based on a Systematic Literature Review. Front. Oncol. [Internet]. 2019;9:715. Disponible en: https://doi.org/10.3389/fonc.2019.00715 9. Reale ML, Di Maio M. Quality of life in patients with lung cancer: the way forward. Lancet Oncol. [Internet]. 2020;21:617-619. Disponible en: https://doi.org/10.1016/S1470-2045(20)30151-0 10. Iyer S, Taylor-Stokes G, Roughley A. Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany. Lung Cancer. [Internet]. 2013;81(2):288–293. Disponible en: https://doi.org/10.1016/j.lungcan.2013.03.008 11. Bdira B, Aissa S, Houda R, Benzarti W, Knaz A, Hayouni A, Abdelghani A, Garrouch A, Benzarti M, Gargouri I. Factors associated with altered quality of life among lung cancer patients. Eur Respir J. [Internet]. 2019;54 (suppl 63) PA4655. Disponible en: https://doi.org/10.1183/13993003.congress-2019.PA4655 12. Bezjak A, Tu D, Seymour L, et al. Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR. 21. J Clin Oncol. [Internet]. 2006;24:3831–3837. Disponible en: https://doi.org/10.1200/JCO.2006.05.8073 13. Reck M, Wehler T, Orlandi F, et al. Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non-Small-Cell Lung Cancer. J Clin Oncol. [Internet]. 2020;38:2530-2542. Disponible en: https://doi.org/10.1200/JCO.19.03158 14. Hazell SZ, Fu W, Hu C, Voong KR, Lee B, Peterson V, Feliciano JL, Nicholas LH, McNutt TR, Han P, Hales RK. Financial toxicity in lung cancer: an assessment of magnitude, perception, and impact on quality of life. Ann Oncol. [Internet]. 2020;31(1):96-102. Disponible en: https://doi.org/10.1016/j.annonc.2019.10.006 15. Ramsey S, Bansal A, Fedorenko C, et al. Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol. 2016;34(9):980e986. Disponible en: https://doi.org/10.1200/JCO.2015.64.6620 Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0. Revista Colombiana de Hematología y Oncología - 2021 https://creativecommons.org/licenses/by-nc-nd/4.0 Español Publication Yepes Pérez , Andrés Revista Colombiana de Hematología y Oncología Asociación Colombiana de Hematología y Oncología (ACHO) application/pdf Calidad de vida cáncer de pulmón 8 1 Núm. 1 , Año 2021 : Enero-Junio Artículo de revista Journal article Quality of life in patients with lung cancer 2256-2915 https://revista.acho.info/index.php/acho/article/download/377/359 2021-10-01T19:10:11Z 2256-2877 2021-10-01T19:10:11Z 9 7 2021-10-01 https://doi.org/10.51643/22562915.377 10.51643/22562915.377 |